Overview

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Status:
Completed
Trial end date:
2008-01-24
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the long-term safety and efficacy of daily administration of teduglutide.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Teduglutide